‘Covering the Tail’ After Stopping Efavirenz-Based Antiretroviral Therapy

Southern African Journal of HIV Medicine - South Africa
doi 10.4102/sajhivmed.v21i1.1036
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AOSIS

Related search

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/R Based Antiretroviral Therapy

PLoS ONE
Multidisciplinary
2013English

New Insight of Antiretroviral Drug Efavirenz as Anticancer Agents for Breast Cancer Therapy

Cancer Cell & Microenvironment
2014English

Relationship Between Plasma Bilirubin Level and Oxidative Stress Markers in HIV-infected Patients on Atazanavir-Vs. Efavirenz-Based Antiretroviral Therapy

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2016English

Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir

AIDS Patient Care and STDs
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2012English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Evolution of Sensory Neuropathy After Initiation of Antiretroviral Therapy

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2017English

Dysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz

Molecular Pharmacology
Molecular MedicinePharmacology
2015English

Changes in Metabolic Syndrome Status After Initiation of Antiretroviral Therapy

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2015English

Efficacy and Tolerability of Lopinavir/Ritonavir- And Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China

Frontiers in Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy